Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital in connection with the sale of Alfa eCare
Mandate

Vinge advises Main Capital in connection with the sale of Alfa eCare

July 10, 2025 M&A Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Employment and Benefits Intellectual Property

Vinge has advised Main Capital in connection with the sale of Alfa eCare Holding AB and its subsidiaries (“Alfa eCare”) to SDB Groep B.V. (“SDB”)

Alfa eCare is a leading provider of digital healthcare, welfare and childcare software in the Nordics. Headquartered in Sweden with offices in Finland and Denmark, Alfa eCare employs approximately 120 people and serves over 1,300 clients across public and private sectors. SDB is a market leading healthcare and childcare software player in the Netherlands, serving elderly care, disabled care, mental health, rehabilitation, youth care, childcare, and independent treatment centers (ITCs).

SDB and Alfa eCare are joining forces to create a leading position in the European Healthcare and Welfare market. The combination establishes a unique player, which offers a comprehensive modular suite of solutions for primary and secondary processes of healthcare and welfare organizations across Europe.

Vinge’s team consisted primarily of Filip Öhrner, Jonatan Stentorp, Ian Linde (M&A), Felix Möller, Sofia Haggren (Banking & Finance), Martin Boström, Siri Blomberg (Commercial Agreements and IT & GDPR), Alice Göransson, Louisa Fagarasan (Employment), Felizia Wiker (IP), Caroline Löv och Jasmina Skandrani (Transaction Support).

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025